It’s been a wild week. The mood was still pretty upbeat on Monday and Tuesday, a little anxiety but a lot of complacency (including mine)… I was in Toronto early this week, with plenty of hand washing and hand sanitizer but no real signs of panic or changes in lifestyle for most folks — the […]
Articles
Personal Finance ($39 for the first year) is a relative low cost “entry level” investment newsletter, the kind that all the big publishers use to recruit the wave of new subscribers who get fed into their marketing “funnel” that generates leads for their higher-priced services… though, to be fair, we also often hear from readers […]
Here’s the scenario of a week ago: China is in the midst of an epidemic of possibly explosive proportions, with fear gripping much of the country (and the world) as a coronavirus spreads and seems to have a pretty high mortality rate, with conspiracy theories abounding and the fear of social unrest as whole cities […]
It’s “goodwill toward all” season, right? So now is the time to get ready to be nice to yourself. I don’t know whether this trade war will end, or if impeachment will lead to something bigger, or whether President Trump will find a way to goose the stock market again next year to boost his […]
Today we’ve got a bit of a quickie for you, mostly just because the clues that were dropped were extremely limited… but it also happens to be a stock I’ve looked at before, so I thought it was worth taking a second look today. Paul Mampilly over the weekend was peddling his True Momentum service […]
Thanks for your kind wishes (and patience) as I took a couple weeks off with my family — we had a wonderful and relaxing getaway in a few of the jewels of the Rocky Mountains as we toured through some northern national parks, most of them blessedly devoid of cell phone service or wifi, but […]
So… anything happen this week? 🙂 We’ll start with a few headline-grabbers from the Real Money Portfolio in the technology world, slide into a little teaser solution for you, and then share some updates on a couple small buys I made, plus some additions to the watchlist, along with the usual blather… Xilinx (XLNX) had […]
Happy weekend, campers! Here’s a good quick read for you to start the weekend from Vitaliy Katsenelson, who is a smarter guy than me. It’s called Want to Be a Better Investor? Stop Staring at Your Portfolio… and it got me thinking a little bit. Here’s a little excerpt: “You spend hundreds of hours on […]
Heydy ho, investing friends! I finally wrap up my Annual Review this week by covering the final three names… and I’ve also got a bunch of other updates to share with you, along with one add-on buy and one brand-new holding for the Real Money Portfolio… enjoy! We’ll start with the completion of the annual […]
Time, once again, for the Annual Review of all of the stocks I hold in the Real Money Portfolio. Many of my positions are built up over many years, and sometimes they’re stocks that don’t generate a lot of news or attention for months at a time, so I promise each January to cover every […]
A fantastic market last week, a terrible market this week… it’s time, once again for another episode of “Turn Off CNBC and Have Some Perspective!” I won’t go into a long screed about long-term investing here, but I thought I’d just share one of my favorite charts — I see someone post something like this […]
Is this the beginning of a 30-60% decline in the stock market? A correction to blow off a little of the excess in the valuations of growth stocks that’s almost over? Something in between? Nobody knows, and it would be silly to spend too much time guessing. We should be prepared for either — which […]
A few purchases to talk to you about today, and a couple other notes as we go… mostly on the theme of risk and safety, as we close out a week with lots of news-driven volatility. Ready? Innovative Industrial Properties (IIPR) is, in some ways, a fun way to “play” the marijuana boom with less […]
Crazy earnings week, eh? That leads me to a few adjustments to the portfolio, as my opinions have changed about a few stocks at the top of the Real Money Portfolio. So this week your Friday File is another run through a hodgepodge of stocks, starting with the one that I think is looking most […]
Today we’ve got a bonanza of content for my favorite people (yes, that’s you!) — a couple quick teaser solutions to close out the week, which morphs right into one little transaction in my portfolio, and then an update on a few other things that are going on with Real Money Portfolio stocks. Ready? OK, […]
CoreSite (COR) announced their latest dividend increase this week, which I’ve been anticipating — would they continue to be a rapid dividend growth REIT and keep investors excited, or will the slowing of the dividend growth continue to make me more cautious about the valuation of this highflier? Well, it turns out that the dividend […]
We’ve seen a long stream of earnings reports and other worthwhile bits of data on Real Money Portfolio stocks since I last wrote to you, including some that actually included some interesting news, so prepare for a lot of quick updates…. Medical Properties Trust (MPW) reported another quarter of ho-hum… pretty much met the forecasts, […]
A few more company updates for you as we finish up the Annual Review… almost done now, though a couple stragglers remain. Medical Properties Trust (MPW) ~2% position, $9.87 cost basis, currently ~12$. I’ve held this volatile hospital REIT for more than four years now, through a couple ignored stop-loss triggers along the way when […]
And our Annual Review proceeds apace… on a day when the market is showing signs of actually having a meaningful correction, thanks to Friday jitters and inflation worries and rising interest rates… so cross your fingers for better prices in the week to come (I did buy a couple positions this week, but as I […]
I’m not going to get as much of a start on the Annual Review as I hoped today, since I took some time to answer the urgent queries about Dr. Kent Moors’ latest LNG pitch and also posted some thoughts about Facebook this morning … but I do have a couple updates on the portfolio, […]
It turned out to be blockchain week here at Stock Gumshoe, with the massive wave of bitcoin-related teasers hitting my inbox, so I should update you on that… The tiny fragment of cryptocurrencies that I still had in my wallets after selling essentially all of those positions in September has once again grown from a […]
How about that bitcoin, eh? Those of you who’ve been following my personal portfolio and reading these Friday Files closely know that I sold pretty much all of my cryptocurrencies back in September, when it got to be a large enough position that I found the cash more valuable. Lots of you think I’m crazy […]
Well, we finish out the week with yet another dramatic performance from the market-dominating tech stocks. Alphabet (GOOG) did better than expected and popped a bit, climbing further through the day, almost as much as the gains Microsoft (MSFT) made on a more dramatic ‘beat’ of expectations (though analysts have always been better at estimating […]
I’ve already shared the major portfolio change I made this week, adding that IPO to my Real Money Portfolio yesterday, and I have also separately posted my notes and thoughts from the CNBC Delivering Alpha conference for my favorite people (yes, that’s you!)…. but I have a couple other things to note as well, so […]
This week I’m breaking up the Friday File into two parts — there was a clamor of request to cover the latest “Code of Life” teaser pitch from Michael Robinson, so I did that for you in a separate piece today… And I’ve also got some comments about recent earnings updates and some other news […]
These kinds of ads always include some huge numbers that sound really, really impressive… here’s a little bit of the intro from the latest ad for Briton Ryle’s The Wealth Advisory: “*Jim T. collected $23,500 last month from ‘backdooring’ Google’s Account *Ron J. ‘backdoored’ $15,804 from Facebook’s Account *Aaron K. pocketed $6,817 last month from […]
We’ve got a veritable smorgasbord for you this week — first, a quick update on one of our Real Money Portfolio stocks, then I’ll take a very quick look at the “Seven Deals” teased by the new Rick Rule Alliance pitch by the Money Map folks, and, finally, I’ll dig into the little hints that […]
This article originally appeared on January 24, 2017. It has not been updated. This ad has generated quite a few questions from Gumshoe readers, and I’ll agree that it sounds pretty enticing (of course, almost all ads do — that’s why they work so well!)… here’s part of the Jim Pearce email that gets the […]
Lots of folks have been asking me about Bitcoin and Ethereum and the other alt-currencies of late, for obvious reasons (well, it’s obvious why folks are curious about it — far less obvious why anyone would seek my wisdom on the subject)… so I’ve got an extended bit of blather about those currencies to share […]
Seriously? Google’s obligated to pay you every month? Well, kind of. But no, not really. This teaser pitch came in from Briton Ryle and the Angel Publishing folks a few times over the past week as they’ve been advertising The Wealth Advisory… and you might be thinking that it sounds kinda familiar. I thought so […]
I’ve got some notes (mostly brief, I hope) to share about the various quarterly earnings reports that have hit my Real Money Portfolio stocks this week… but I have gotten a pile of reader questions so I wanted to start with a look at Sandstorm Gold (SAND), which announced a pretty big deal earlier in […]
I’ve gotten a few questions about Jason Williams’ free Wealth Daily article on Friday that hinted at “Warren Buffett’s Next Target,” so I thought we’d take a moment to throw those clues into the ol’ Thinkolator for you. There is a cottage industry on Wall Street right now that really demonstrates the short-termism of the […]
We’re closing in on the end of my annual navel-gazing exercise in portfolio review, and today it’s time to look at the “income” stocks in my portfolio. During the week next week I’ll catch up with a few smaller positions that don’t fit into the neat sectors I’ve divvied up thus far, like Disney, for […]
Today I continue my annual navel-gazing for you, as I look at each position in my portfolio — though this year, as I mentioned in our kickoff last week, I’m changing the way I describe, report and follow these stocks for you, largely so that I can be clearer about my preferences and opinions and […]
We’re breaking things up a little bit today for the Friday File — this piece is about some investments that interest me personally, and I’ve also got a teaser solution piece for the Irregulars today that you can see here. The investments that are most appealing to me right now are both in the technology […]
NXP Semiconductor (NXPI) and Visteon (VC) both reported results this week, both pretty much in line with what I would have expected and pretty close to analyst estimates (Visteon earnings were well above estimates, revenue well below because analysts have a hard time getting very specific on Visteon quarters — but their big picture remains […]
There are a couple interesting equity-oriented presentations at the Grant’s conference that I wanted to think through a little bit more today… … the first one was from Mark Cohodes, a legendary short seller who is semi-retired now but still takes on a few targets from time to time. And gives a great, profanity-laced presentation. […]
I’ll be fairly brief today with my Friday musings for you today, because I’m off to the Grant’s Interest Rate Observer Conference on Tuesday next week and I expect I’ll be writing a few extra notes for the Irregulars based on what I see in those presentations. I’m particularly interested in hearing the thoughts of […]
Time for some “Idea of the Month” thoughts for you, dear Irregulars. When you think the investing climate is a little more nerve-wracking than usual, why not go with a master investor who’s also nervous and is preparing for an awful economy? I’ve spoken quite a few times about my fondness for insurance company stocks. […]
Before I begin talking about this month’s stock idea, a brief update: I added a little bit to my Coresite (COR) holdings late yesterday. I’ve been hoping for lower prices down to the low $70s, but at $78 I can at least make a more rational argument for the stock than I could when it […]
I won’t be able to post our regularly-scheduled Friday File for you this week, since I’ll be preparing for my ride this weekend (thanks again to the many of you who have sponsored me!), and Stock Gumshoe will be very quiet next week because I’ll be on vacation with my family (and recuperating, I imagine), […]
This week I’ve got a lot of thinking to catch up on — there are several stocks in our Gumshoe Universe that have reported or generated some news of late, many of which I own, and I’ve got some thoughts on a lot of them to share with you. I started with my reaction to […]
I noted on Friday that I had added to my Douglas Dynamics (PLOW) holdings following their recent acquisition of Dejana… so I should note that this morning, ratings agencies gave PLOW a little slap on the wrist for their term loan — it is a leveraged company, so they downgraded the term loan by one […]
Timothy Lutts is hinting at a new small cap stock in order to tantalize potential subscribers to Cabot Small-Cap Confidential 2.0 (which will run you $950/year), and the line that caught my eye was “A Rare Second Chance to Turn $5,000 into $40,000.” That’s a reference to Tesla, which had such an 800% jump (over […]
This week we don’t have a new teaser solution for your Friday File pleasure, so I’ll stick with some updates on a few stocks I’ve been watching this week… and next week, we’ll get our “Idea of the Month” piece up for you. And we also have a new piece from Dr. KSS up today, […]
As we enter mid-February and a slow week in Gumshoeland next week, I’ve got a few personal buys of stocks that we’ve mentioned before, and a new “Idea of the Month” candidate that’s maybe not quite ready to buy just yet (we’ll be closed on Monday, and will probably publish less than usual during the […]
Each year I go through all of the stocks that I either own personally or have brought to the attention of the Irregulars (there’s quite a bit of overlap on those lists), and I make sure to update my thoughts and opinion on that stock in an organized and, hopefully, disciplined way — that helps […]
We have had a long line of questions about the misleading “Internet Royalties” teaser from The Wealth Advisory, so I’m going to re-share that one. My initial solution for this teaser pitch appeared at the tail end of a Friday File for the Irregulars (our paid members) on September 12, 2014, so many of you […]
Today, for your Friday File edutainment, a look at a teaser pitch from Keith Schaefer about a junior oil company. I know, I know — oil is collapsing. But this is a company that doesn’t even really own anything yet, and almost certainly won’t be producing any oil for at least a couple years, so […]
This is just silly. Politicians always find their names appropriated by newsletter ad campaigns, because it’s an easy way to catch your eye — you’re already (or maybe not you, but lots of folks) feeling passionate about Donald Trump, or Hillary Clinton, or President Obama or whoever… so if those names are blazoned across an […]
[unlocked for free readers on October 7, 2015] Did you notice that Dr. Kent Moors is out again with his “trade has hit green light status” teaser pitch for his Energy Inner Circle newsletter? The ad is about an options trade he’s recommending on the US Oil ETF (USO), and we wrote about it back […]
We’ve been on strange schedules here in Gumshoeland for the last two weeks, and during that time we’ve seen a large number of quarterly reports come through that deserve some attention or comment… as well as a few other notable news items that I feel like I should pay attention to. And, of course, we’ve […]
I’m feeling a little bit old today because my fourth baby, Stock Gumshoe, just celebrated its eighth birthday. Eight years of solving teasers, sharing thoughts, and defusing marketing hype… and it’s still such a cute little fella! I certainly never expected this to grow and get the attention of so many people when I sat […]
I’m still in the “accumulation” phase of my financial life — I’m trying to add to my savings and investment accounts as aggressively as a I can, and keeping my eye out a couple decades to what my holdings might do before I retire. Assuming I ever retire. So my perspective is, I know, quite […]
I’ve got a half dozen notes and comments on companies I own and follow for your Friday File pleasure today, but first I want to toss out a teaser solution for you to chew on… it’s a fun one. The pitch is from Keith Kohl for his new High Yield Energy Report, a newsletter that […]
I don’t have a single idea that makes me want to jump up and down this month — I’ve been trickling more money into Pershing Square Holdings (PSH.AS, PSHZF) and Tekla Healthcare (THQ) as well as more boring broad index funds and such, and have been tempted by some other investments, but nothing jumps out […]
I haven’t looked at the Capital Wave Forecast stuff from Shah Gilani in quite a while, so the latest teaser pitch from him and the Money Map folks caught my eye — particularly because he’s touting big moves in specific large-cap “blue chip” type stocks, which is pretty rare in newsletterdom (it’s a lot easier […]
All of you, dear Irregulars, know that Stock Gumshoe is not a “tip sheet,” and I don’t operate a portfolio for other people to emulate or copy, or even attempt to track the stocks we cover as if they were a portfolio of buys and sells with consistent trading advice… but I do keep a […]
I always get a lot of food for thought when I go to the Value Investing Congress, so I’ve got a teaser solution and some updates for your Friday File enjoyment but I thought I’d start with some musing about the Congress ideas that percolated to the top for me on the train ride home… […]
A hodgepodge of thoughts and comments to catch up with thoughts on a few companies that have reported quarterly results or had other meaningful news as I was on vacation — and a quick note on a small buy. First, I need to let you know that I bought a few JP Morgan warrants (JPM-WT) […]
First, let me welcome all of the new members who’ve joined us during this week’s charitable membership drive — you are wonderful people, and it is a delight to work for you every day. I am a little overwhelmed with just how successful our charity drive has become, we’ve now already surpassed last year’s total […]
Today is a fun day for every value investor out there — it’s the day Warren Buffett’s annual letter to shareholders comes out. So for God’s sake, don’t waste too much time with your friendly neighborhood Gumshoe if you haven’t read that one yet. You can get to it here if you’re curious, or check […]
I have to give the Motley Fool Rule Breakers folks credit on this one — they’ve been touting this stock consistently for just about two and a half years now, and it has, despite the fact that it always looks kind of expensive, refused to spend much time going down during that time. But every […]
“How you can protect yourself and profit with one quick move” That quick move that Mike Cintolo of the Cabot Market Letter is suggesting is, you will be unsurprised, subscribing to the Cabot Market Letter. But the Cabot folks are, in the main, growth investors who are driven by technical analysis (meaning, to oversimplify, that […]
I’ve spent the past couple weeks going over my updated opinions on all of the past “Idea of the Month” stocks (or at least, those that haven’t already been dropped from coverage over the years), and I promised to put them all in one big list in order of likingness (yes, I know it’s not […]
The annual parade continues — I’m updating my thoughts on the stocks I’ve suggested in the past as “Idea of the Month” investments, and in this installment we’re looking at what are mostly dividend-growth stocks: income ideas, but not stocks that have particularly huge current dividends (those “bigger yielders” were covered in Part one here). […]
The folks at the Motley Fool have run lots of ads for stock picks that “piggyback” on the iPhone’s gargantuan success — as have lots of other newsletter publishers, of course — and it looks like that trend will continue. The ad I’ve seen today takes a somewhat different tack on this same basic idea […]
The folks at the Motley Fool have been promoting Dave Gardner’s Rule Breakers newsletter for years by using the same basic theme for their ads: Cloud computing scared Bill Gates into retirement, and the “Kings of Cloud Computing” in the next era will make you rich. If you’re not familiar with Gardner, he’s basically a […]
The markets are debt-obsessed once again, I’m afraid — not corporate debt, as they were in 2008 and 2009 when any company with leveraged was thrown out the window, but gummint debt. I don’t know whether this will be a real “reckoning” for the US government, when we really take stock of our obligations and […]
One of the ideas that I’ve been coming back to again and again is infrastructure — not necessarily just the kind of physical infrastructure that I talked about last month with Ferrovial, or things like power and highways and pipelines, but the basic kind of underlying businesses that keep other businesses operating. And in the […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Dr KSS was right on this one!...
Dr KSS wouldn't come back to this site to let us know if he were getting back into $ARTH as he's totally leading the Bio...
Claude Please note that Dr KSS has left this building. He no longer reads or posts here. You responded to a note that...
beat Dr KSS sugar diet topic assignment ZKSS beat Dr KSS sugar diet topic assignment ZKSSbeat Dr KSS sugar diet topic as...
beat Dr KSS sugar diet topic assignment ZKSS beat Dr KSS sugar diet topic assignment ZKSSbeat Dr KSS sugar diet topic as...
beat Dr KSS sugar diet topic assignment ZKSS beat Dr KSS sugar diet topic assignment ZKSS...
beat Dr KSS sugar diet topic assignment ZKSS...
beat Dr KSS sugar diet...
$AFMD NP tanglewood - Thanks for saying when Dr KSS mentioned it as I had no recollection at all of the stock....
More on $AFMD. Dr KSS first mentioned it in 'The Rest of the 12 Biotechs of Christmas' published on Feb 9,2017. At the ...
Thank you Ben for that info. I am still long this stock when Dr KSS first recommended it. Cost basis $2.26 per share on ...
$AUPH - Actually, in my experience, Helen can be terrific on holding hands. And so I'm clear: I did not, and would not, ...
$AUPH - etc. Keep in mind Helen uses technicals as well as science. One reason I chose not to follow Dr. KSS also applie...
Dear Dr KSS -- Thanks very much for this insightful review of cancer and its treatment in mainstream medicine. Your com...
Thanks for sharing, Jerome. I inquired awhile back if anyone out there smarter than I (that really opens it up) had any ...
STM, I couldn't agree more. I think KSS did have great insight into the science that he shared freely (early on at least...
$ARTH New Theme: "Dr. KSS program to make Stock Gumshoe great again: Arbitrarily kick people out of Biopubkss" ...
$ARTH $CWBR STM To be honest I hope we can just be on one thread. Gets too confusing. Dr. Norchi is the most car...
#Cleveland Apology Glad you brought it up. I was thinking about it. I do apologize to you and Hippockets and all. I w...
Off topic a bit (though it is related to small biocaps), but do you Travis, or anyone else know what became of the Newsl...
Oh Oh; it looks like the cat is out of the bag! So sarah you are the famous Alan Harris from Dr. KSS biotech thread....
1. I don’t think that the SPLC is in any way a “terrorist organization.” 2. Lifetime memberships are non-refun...
$AKAO I think you hit the nail on the head STM. It would not surprise me if the FDA votes for approval for the BSI indic...
Plus...no Dr Kss for guidance on the medicine. I would not have gone into the sector at all without someone like him e...
The majority of money I have lost in the stock market has been due to following the advice of Dr. KSS so I for one will ...
$AUPH And then there was one..... As Dr. KSS predicted before he left, ImmuPharma's Lupuzor P3 for the treatment of Sy...
Why pray tell would anyone TD any of Ben's posts? What agenda would anyone have, sycophant or not, to derive pleasure ...
$CWBR, Are you saying that DR KSS and Cleveland have sold their shares?...
ptn $1.36 DR.KSS said he was still holding.That was about a year ago....
The new conference call with Dr KSS will be Friday 4/6 @ 12:30ET. Usual protocol - (712)770-4063 then 850326#. Callers w...
$Dr KSS Looks like I subscribed in time yesterday. Did it via PayPal to my bank acct. Sorry I broke the system. :(...
$DR. KSS $DR. Relentless THE NEW DR. KSS WEBSITE IS UP AND RUNNING!!! biopubkss.com...
SG Newsletters - FWIW - Many years ago, when I was grasping for valid information about biotech, and was a GS newbie, I ...
Frankly, Cleveland, if you will remember how hostile you were towards me, you might realize why I felt I could not have ...
Cleveland - I may be in the minority, which bothers me not at all, and I sincerely appreciate your comment(s). I've bee...
Does dr kss have a column or is the only access through twitter?...
I sold out when the market opened. Later I saw that Dr. KSS sold as well....
For those of you who were unable to participate in the conference call today with Dr. KSS and Processa Pharma, here is t...
# Conference Call Date Jim - I was simply replying to your post which stated, "A new conference call with Dr. KSS will ...
$APTO, ow - has been doing its own version of March Madness with CEO Rice (accompanied by CFO Chow) making presentations...
A new conference call with Dr. KSS will take place this Friday (10/23) at 12:30pm ET. The primary purpose is to showcase...
I'm out of $PTI. Dr. KSS spoke favorably of Julia S-S. Left with a modest profit....
$SNDX also out with nice profit! Thanks Dr KSS!...
$SRNE $VTGN - According to my notes, Dr. KSS said Sorrento went through a tumultuous time, but he thinks "they're go...
$RTTR For those who think institutions don't buy penny stocks....baker bros are long this one under 0.30 cents. Dr Kss ...
$SRNE np - Dr KSS on the call yesterday said 'to be cautious' with SRNE. He talked a bit about why, but I did not write...
Where do we find the List of the 12 Dr KSS stocks ?...
many thanks, Jim and Dr Kss....
$Ø Thanks for doing this Jim. As I'm not an active Twitter poster I hope someone will relay my thanks to Dr KSS for...
Comments copied from the biotech-discussion-continued thread on 3/8/18: vmsk33094 JoeS you wrote on 3/7/2018 that A...
$Conference Call 9.3.18 No this is a call which Dr KSS has referred to on Twitter. It looks as though he will be conduc...
$APTO Joe, Dr KSS said on 23.01.18 - "I predict that (lifting of clinical hold) will come during the 3rd week of Mar...
Here’s several comments about $APTO that were posted to the biotech-discussion-continued thread. ==================...
From https://www.stockgumshoe.com/2018/02/microblog-discussion-page-for-aurinia-pharmaceuticals-auph/ (a dedicated thre...
The $AUPH tab on the spreadsheet at http://tinyurl.com/KSSDAMAN has been updated with the latest comments from Dr. KSS....
$APTO long. This must be a significant milestone for Aptose. Dr. Rice and Greg Chow are presenting at 4 investor confe...
$Conference call with DR KSS Friday, March 9, at 12:30pm ET. To participate: Dial (712) 770-4063, and when prompted inpu...
I (Doc Gumshoe) am staying with Stock Gumshoe - who bailed was Dr KSS. I wish him good fortune. I'll be on this webs...
$FATE ow taxable, this company is so diverse and grown so quick I forgot why I was in it. Also $ARTH ow taxable, green, ...
Travis, you might be too young to remember Paul Harvey, an ABC radio personality in the late 1900s. He was famous for...
#CURT Thanks. I am no saint or qualified for President. I just happen to have met the person #DRKSS. Since 2015 I w...
$ARTH ow and biggest holding: Hi Cleveland, still glad you are here brother! This is my first post in a while as I h...
Would someone provide the Dr KSS conference call replay number. I missed the call and the announcement....
Cleveland - Do you know whether DR KSS is working on a new (service) site?...
Cleveland - I really miss your commentary. I've been a huge fan since you saved my tail w/$CLRBZ. I deeply regret ANY ...
Pgathua, Glad to tell you everything I know (which I'm afraid isn't much) but I'm not business oriented enough to do mea...
In Feb. of 2016, Dr. KSS indicated a lack of enthusiasm for $EDIT....
Both Dr KSS and Helen have recommended $DMCAF on Twitter; also Oncolytics....
$DMCAF - np (sadly) - Looks like the jump coincides with the Dr KSS tweet that he quadrupled his position in it. I wa...
If you missed the S&P run because of investing in biotech, you should really do yourself a favor and learn to diversify ...
porgie - I don't think many here followed Dr. KSS like sheep. With that said, his background is none of my business; I ...
Ben, Roger, STM, et al - I have been following two stocks for personal reasons as well as investments - $AVXS and $RGNX....
Anyone else here invested in $CORT or have an opinion on this company? Lately I've been reading the following blog - ht...
Hi Porgie. I owned $SNDX for a while as well but sold out once I took another look at the phase 2 data for E2112 - HR+, ...
There are plenty of intelligent people who post here. If you don't know who they are and aren't willing to read anything...
It's too bad, too. All these folks were very bright and added a lot to the discussion. Hard to believe they all had such...
Had a great day. Thank you Dr. KSS and Helen....
And he posted his hateful vile on the internet to gain emotional revenge on the good Doc. You forgot that part. Just pla...
$CYDY np - this is why it would be so nice if Dr. KSS were still with us. The release above sounds and reads like good ...
$Dr.KSS stock recommendations I have been following some of this and other recent biotech thread’s discussions on the ...
Does anyone know the twitter address for Dr KSS? Thanks in advance!!...
$CAPR np, DR KSS latest tweet: "They got the regenerative medicine nod from FDA they'd been seeking. I had honestly pred...
STM thanks for the update. From the stocks from your portfolio i have an observation and potential income earner. $CLRB...
Even knowing what I know now...I would still invest with Dr KSS but that information would have been nice to know. Blata...
Cleveland - I miss you, Doc, LinLing, et al. Those posting negatives about Dr. KSS, in my opinion, are shown to be cow...
The true facts are that Dr Kss is very knowledgeable and saved all of us from lots of pitfalls but he also harmed a lot ...
Mary...can I list all the neuro plays Dr Kss stubbornly advanced here ..even after being questioned a few times. $CUR be...
mzimmer wrote: "Same with $TTPH. It was supposed to have doubled. Just bombed today." DR KSS on $TTPH: "Don't be a su...
Cleveland - I am trying to negotiate Twitter and would like to follow you if you are on there - I found Helen and I thin...
Dr KSS is the best source on the science behind bios that I've come across. My big regret is only finding him a year or ...
We live in an age where people on the board of local public school systems routinely receive death threats. DR KSS may n...
Totally !! Shameful !! Richardo: "Regardless of what you think or have read about Dr. KSS, for someone to denigrat...
cleveland- any update on when/if Dr KSS will have a new site available? I suppose you could contact me through Travis if...
Why 3 thumbs down for Cleveland (well now it is only 2) Cleveland is an honorable,man who has worked his a** off for us...
#Pure Hypocrisy Trash Dr. KSS viciously trying to harm him emotionally and then you pitch one of his picks????? Path...
$apto ow Not sure if there's anyone left here who can weigh in. There was a discussion on twitter, someone posed a quest...
$APTO ow I'm goin' on Dr. KSS' recommendation on this one and looking for some catalysts in the upcoming months. As fa...
The reaction of Dr.Kss is good enough for me !!!...
Roger, I am glad that KSS has a loyal friend, but I find your confusing of character and intellect confounding. A spark...